---
title: "Ventyx Biosciences (VTYX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VTYX.US/norm.md"
symbol: "VTYX.US"
name: "Ventyx Biosciences"
parent: "https://longbridge.com/en/quote/VTYX.US.md"
datetime: "2026-03-08T02:20:39.311Z"
locales:
  - [en](https://longbridge.com/en/quote/VTYX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VTYX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VTYX.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/VTYX.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/VTYX.US/norm.md)


# Ventyx Biosciences (VTYX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.3202 | -0.3790 | -0.3858 | -0.4145 | -0.4988 |
| ROE | -45.57% | -48.95% | -45.20% | -44.07% | -50.39% |
| Revenue | - | - | - | - | - |
| Net income | -22.83M | -26.99M | -27.44M | -29.35M | -35.25M |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 211.47M | 230.01M | 253.48M | 276.56M | 301.10M |
| Leverage | 1.10 | 1.10 | 1.09 | 1.09 | 1.08 |
| BVPS | 2.68 | 2.94 | 3.25 | 3.57 | 3.94 |
| Turnover | - | - | - | - | - |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -17.51M | -21.28M | -25.72M | -23.25M | -35.46M |
| Investing CF | 17.05M | 25.19M | 26.41M | -11.00M | 29.25M |
| Financing CF | 203000.00 | 68000.00 | - | -25000.00 | 26.86M |
| Free CF | -9.02M | -11.06M | -15.31M | -12.07M | -21.27M |
